ASKA Pharmaceutical Holdings Co Ltd 2023 Annual Report with Sustainability Disclosures
Company: ASKA Pharmaceutical Holdings Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2023
Type: Annual Report with Sustainability Disclosures
Pages: 115
The report describes the company's ESG governance, including an ESG Committee that identifies company-wide material issues and determines ESG strategy. It reports FY2022 Scope 1 emissions of 6,687 and Scope 2 emissions of 4,093 t-CO2, with annual third-party verification of environmental indicators. Human-capital priorities include a target of 15% female managers by March 2025 and progress on parental-leave participation.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.